Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study on the Safety and Feasibility of Bevacizumab-800CW Imaging for Patients with Barrett’s Esophagus, Colon Cancer, or Gastrointestinal Dysplasia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Pembrolizumab for Patients with Localised dMMR Colon Cancer: Neoadjuvant and Organ-Sparing Treatment Study

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study on Pembrolizumab and Drug Combination for Patients with Localized Colon Cancer with Specific Genetic Markers

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study on the Effectiveness of Aspirin in Patients with Resected Colon Cancer with PI3K Mutation Stage III or II High Risk

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium France
  • Study on Oxaliplatin for Reducing Recurrence Risk in High-Risk Colon Cancer Patients After Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study on the Effects of Capecitabine and Oxaliplatin in Patients with Locally Advanced Colon Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Norway
  • Study on Aspirin’s Effect on Recurrence and Survival in Patients with Non-Metastatic Breast, Colon, Rectal, Stomach, Esophageal, and Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Ireland
  • Study on Selpercatinib for Adults with Advanced or Metastatic Solid Tumors with RET Activation

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France Italy Poland Spain